Mount Sinai Hospital, Canada: Diabetes Mellitus, Type 2 trials

The registry lists 12 Diabetes Mellitus, Type 2 studies with Mount Sinai Hospital, Canada as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 3 5Phase 4 1No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Time Restricted-EAting for Type 2 Diabetes and MEtabolic Health: the TEA TIME TrialRecruitingNCT07272460Not applicable
• Time Spent In Target Glucose Range in Women With T2D Diabetes in PregnancyRecruitingNCT06147466
• Metabolic Impact of Intermittent Fasting in Early Type 2 DiabetesCompletedNCT05717127Not applicable
• Diabetic Ketoacidosis From New SGLT2i: Can Genomics Estimate RiskCompletedNCT05402579
• The Effect of In-utero Exposure to Metformin in 5-11 Year Old Offspring of Mothers in the MiTy TrialCompletedNCT05025852
• Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)CompletedNCT02194595Phase 3
• Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial)CompletedNCT02192424Phase 3
• MiTy Kids (Metformin in Women With Type 2 Diabetes in Pregnancy Kids Trial)CompletedNCT01832181
• Blood Pressure Outcomes With Liraglutide TherapyCompletedNCT01755572Phase 4
• Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Pilot Study)CompletedNCT01755468Phase 3
• Metformin in Women With Type 2 Diabetes in Pregnancy TrialCompletedNCT01353391Phase 3
• LIraglutide and Beta-cell RepAir (LIBRA) StudyCompletedNCT01270789Phase 3